NASDAQ:MNKD - Nasdaq - US56400P7069 - Common Stock - Currency: USD
Overall MNKD gets a fundamental rating of 5 out of 10. We evaluated MNKD against 563 industry peers in the Biotechnology industry. MNKD has only an average score on both its financial health and profitability. MNKD is not priced too expensively while it is growing strongly. Keep and eye on this one!
Industry Rank | Sector Rank | ||
---|---|---|---|
ROA | 7% | ||
ROE | N/A | ||
ROIC | 20.74% |
Industry Rank | Sector Rank | ||
---|---|---|---|
OM | 25.07% | ||
PM (TTM) | 9.66% | ||
GM | 74.19% |
Industry Rank | Sector Rank | ||
---|---|---|---|
Debt/Equity | N/A | ||
Debt/FCF | 8.83 | ||
Altman-Z | -7.58 |
Industry Rank | Sector Rank | ||
---|---|---|---|
Current Ratio | 3.28 | ||
Quick Ratio | 2.94 |
Industry Rank | Sector Rank | ||
---|---|---|---|
PE | 59.75 | ||
Fwd PE | 25.63 |
Industry Rank | Sector Rank | ||
---|---|---|---|
P/FCF | 44.26 | ||
EV/EBITDA | 18.35 |
Industry Rank | Sector Rank | ||
---|---|---|---|
Dividend Yield | N/A |
4.78
-0.18 (-3.63%)
Industry Rank | Sector Rank | ||
---|---|---|---|
Dividend Yield | N/A |
Industry Rank | Sector Rank | ||
---|---|---|---|
PE | 59.75 | ||
Fwd PE | 25.63 | ||
P/S | 5.09 | ||
P/FCF | 44.26 | ||
P/OCF | 34.17 | ||
P/B | N/A | ||
P/tB | N/A | ||
EV/EBITDA | 18.35 |
Industry Rank | Sector Rank | ||
---|---|---|---|
ROA | 7% | ||
ROE | N/A | ||
ROCE | 22.94% | ||
ROIC | 20.74% | ||
ROICexc | 56.39% | ||
ROICexgc | 60.16% | ||
OM | 25.07% | ||
PM (TTM) | 9.66% | ||
GM | 74.19% | ||
FCFM | 11.49% |
Industry Rank | Sector Rank | ||
---|---|---|---|
Debt/Equity | N/A | ||
Debt/FCF | 8.83 | ||
Debt/EBITDA | 3.39 | ||
Cap/Depr | 131.5% | ||
Cap/Sales | 3.4% | ||
Interest Coverage | 4.09 | ||
Cash Conversion | 53.84% | ||
Profit Quality | 118.96% | ||
Current Ratio | 3.28 | ||
Quick Ratio | 2.94 | ||
Altman-Z | -7.58 |